Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutated patients: An evidence-based approach on what women should know.

Cancer treatment reviews - 1 Dec 2017

De Felice F, Marchetti C, Boccia S M, Romito A, Sassu C M, Porpora M G, Muzii L, Tombolini V, Benedetti Panici P

Abstract excerpt

This review is focused on the ovarian cancer risk reduction management in BRCA mutation carriers and is intended to assist with clinical decision-making. Obviously, treatment decisions must be based on the available evidence. Despite risk-reducing salpingo-oophorectomy is firmly recommended, several separate questions can be raised to address the variety of intense controversy of this approach. A special emphasis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 gene
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Genetic Predisposition to Disease

Share to Germ-Line Mutation

Share to Ovarian Neoplasms

Share to Risk Reduction Behavior

Share to Salpingo-oophorectomy

Source

Identifiers

PMID: 29028552
DOI: 10.1016/j.ctrv.2017.09.005

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutated patients: An evidence-based approach on what women should know.PMID 29028552Read ↗

Ovarian cancer risk management in BRCA-mutation carriers: A comparison of six international and national guidelines.Semantic proximity Read ↗

Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery.Semantic proximity Read ↗

Prophylactic salpingectomy with delayed oophorectomy as a two-staged alternative for primary prevention of ovarian cancer in BRCA1/2 mutation carriers: women's point of view.Semantic proximity Read ↗

Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Hereditary Women's Cancer: Management and Risk-Reducing Surgery.Semantic proximity Read ↗

Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act.Semantic proximity Read ↗

Hormone replacement therapy in healthy BRCA1 and 2 mutation carriers after risk-reducing salpingo-oophorectomy: A 5 Ws and 2 Hs practitioner toolkit.Semantic proximity Read ↗

Risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 or BRCA2 mutation carriers: A systematic review and meta-analysis.Semantic proximity Read ↗

Risk-reducing surgery in BRCA 1/2 mutation carries: a point of view.Semantic proximity Read ↗

Risk-reducing surgery on the uterine adnexa: timing and type of surgical treatment, and pathology report.Semantic proximity Read ↗

Counselling of path_BRCA carriers who are considering risk-reducing oophorectomy.Semantic proximity Read ↗

[Risk-reducing surgery in women at hereditary risk of gynaecological cancer].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.